Retina (Philadelphia, Pa.) · 2025
TREATMENT OF CHOROIDAL METASTASIS WITH COMBINED PHOTODYNAMIC THERAPY AND BEVACIZUMAB AND COMPARISON WITH PHOTODYNAMIC THERAPY ALONE.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aykut Aslan, Sarigul Sezenoz Almila, Beser Buse Guneri, Juntipwong Sarinee, Alizade Mehriban, Demirci Hakan
Аннотация
PURPOSE: To evaluate the efficacy of the treatment of choroidal metastasis with combined photodynamic therapy (PDT) and intravitreal bevacizumab (IVB) and compare it with PDT alone.
METHODS: Retrospective analysis of 41 choroidal metastatic tumors: 19 tumors (13 patients) treated with PDT + IVB versus 22 tumors (8 patients) treated with PDT alone between 2011 and 2023. Outcomes measured included best-corrected visual acuity, tumor dimensions, central macular thickness, and subretinal fluid at baseline, 6 weeks, and final follow-up.
RESULTS: With median follow-up of 7 (range: 3-84) months, the PDT + IVB group showed significantly better outcomes than the PDT alone group: improved best-corrected visual acuity at 6 weeks and final visit ( P = 0.02), higher complete subretinal fluid resolution at 6 weeks (68% vs. 27%, P = 0.002), and significant decrease in tumor thickness at both timepoints ( P = 0.04 and P = 0.004). The PDT alone group showed no significant change in tumor thickness. Tumor control rates (defined by fluid resolution and decreased thickness) were superior in the PDT + IVB group at 6 weeks (73.3% vs. 26.6%, P = 0.009) and final visit (92% vs. 47%, P = 0.01).
CONCLUSION: This first series using combined PDT + IVB for choroidal metastasis demonstrates superior early and long-term functional and anatomical outcomes compared with PDT alone, suggesting it as a more effective management approach.
METHODS: Retrospective analysis of 41 choroidal metastatic tumors: 19 tumors (13 patients) treated with PDT + IVB versus 22 tumors (8 patients) treated with PDT alone between 2011 and 2023. Outcomes measured included best-corrected visual acuity, tumor dimensions, central macular thickness, and subretinal fluid at baseline, 6 weeks, and final follow-up.
RESULTS: With median follow-up of 7 (range: 3-84) months, the PDT + IVB group showed significantly better outcomes than the PDT alone group: improved best-corrected visual acuity at 6 weeks and final visit ( P = 0.02), higher complete subretinal fluid resolution at 6 weeks (68% vs. 27%, P = 0.002), and significant decrease in tumor thickness at both timepoints ( P = 0.04 and P = 0.004). The PDT alone group showed no significant change in tumor thickness. Tumor control rates (defined by fluid resolution and decreased thickness) were superior in the PDT + IVB group at 6 weeks (73.3% vs. 26.6%, P = 0.009) and final visit (92% vs. 47%, P = 0.01).
CONCLUSION: This first series using combined PDT + IVB for choroidal metastasis demonstrates superior early and long-term functional and anatomical outcomes compared with PDT alone, suggesting it as a more effective management approach.
Предметные рубрики MeSH
HumansBevacizumabPhotochemotherapyRetrospective StudiesChoroid NeoplasmsFemaleMaleAngiogenesis InhibitorsAgedIntravitreal InjectionsMiddle AgedVisual AcuityPhotosensitizing AgentsFollow-Up StudiesVerteporfinTomography, Optical CoherenceFluorescein AngiographyAdultTreatment OutcomeAged, 80 and overCombined Modality TherapyFundus OculiChoroid